Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: Importance of G2019S and R1441C mutations in sporadic Parkinson's disease patients

Parkinsonism and Related Disorders

Volumn 15, Issue 4, 2009, Pages 277-280

  Floris, Gianluca ^a   Cannas, Antonino ^a   Solla, Paolo ^a   Murru, Maria Rita ^b   Tranquilli, Stefania ^b   Corongiu, Daniela ^b   Rolesu, Marcella ^b   Cuccu, Stefania ^b   Sardu, Claudia ^b   Marrosu, Francesco ^b   Marrosu, Maria Giovanna ^a  

^a Centro per i Disordini del Movimento   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

LRRK2; Parkinson's disease

Indexed keywords

LEUCINE RICH REPEAT KINASE 2; LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HETEROZYGOTE DETECTION; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PARKINSONISM; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ARGININE; CYSTEINE; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; GLYCINE; HUMANS; ITALY; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; POPULATION GROUPS; PROTEIN-SERINE-THREONINE KINASES; SERINE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 64249087346     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2008.06.009     Document Type: Article

References (29)

1. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 5321 (1997) 2045-2047
2. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392 6676 (1998) 605-608
3. Bonifati V., Rizzu P., Squitieri F., Krieger E., Vanacore N., van Swieten J.C., et al. DJ-1 (PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol Sci 24 3 (2003) 159-160
4. Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M., Harvey K., Gispert S., et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304 5674 (2004) 1158-1160
5. Paisan-Ruiz C., Jain S., Evans E.W., Gilks W.P., Simon J., van der Brug M., et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44 4 (2004) 595-600
6. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44 4 (2004) 601-607
7. Funayama M., Hasegawa K., Kowa H., Saito M., Tsuji S., and Obata F. A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol 51 3 (2002) 296-301
8. Gilks W.P., Abou-Sleiman P.M., Gandhi S., Jain S., Singleton A., Lees A.J., et al. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 365 9457 (2005) 415-416
9. Kachergus J., Mata I.F., Hulihan M., Taylor J.P., Lincoln S., Aasly J., et al. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet 76 4 (2005) 672-680
10. Nichols W.C., Pankratz N., Hernandez D., Paisan-Ruiz C., Jain S., Halter C.A., et al. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 365 9457 (2005) 410-412
11. Di Fonzo A., Rohe C.F., Ferreira J., Chien H.F., Vacca L., Stocchi F., et al. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 365 9457 (2005) 412-415
12. Lesage S., Leutenegger A.L., Ibanez P., Janin S., Lohmann E., Durr A., et al. LRRK2 haplotype analyses in European and North African families with Parkinson disease: a common founder for the G2019S mutation dating from the 13th century. J Hum Genet 77 2 (2005) 330-332
13. Ozelius L.J., Senthil G., Saunders-Pullman R., Ohmann E., Deligtisch A., Tagliati M., et al. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med 354 4 (2006) 424-425
14. Kay D.M., Zabetian C.P., Factor S.A., Nutt J.G., Samii A., Griffith A., et al. Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics. Mov Disord 21 4 (2006) 519-523
15. Lesage S., Ibanez P., Lohmann E., Pollak P., Tison F., Tazir M., et al. G2019S LRRK2 mutation in French and North African families with Parkinson's disease. Ann Neurol 58 5 (2005) 784-787
16. Bonifati V. LRRK2 Low-penetrance mutations (Gly2019Ser) and risk alleles (Gly2385Arg)-linking familial and sporadic Parkinson's disease. Neurochem Res 32 10 (2007) 1700-1708
17. Goldwurm S., Zini M., Mariani L., Tesei S., Miceli R., Sironi F., et al. Evaluation of LRRK2 G2019S penetrance: relevance for genetic counseling in Parkinson disease. Neurology 68 14 (2007) 1141-1143
18. Gelb D.J., Oliver E., and Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 56 (1999) 33-39
19. Marder K., Levy G., Louis E.D., Mejia-Santana H., Cote L., Andrews H., et al. Accuracy of family history data on Parkinson's disease. Neurology 61 (2003) 18-23
20. Goldwurm S., Di Fonzo A., Simons E.J., Rohe C.F., Zini M., Canesi M., et al. The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor. J Med Genet 42 11 (2005) 65
21. Zabetian C.P., Samii A., Mosley A.D., Roberts J.W., Leis B.C., Yearout D., et al. A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Neurology 65 5 (2005) 664-665
22. Cossu G., van Doeselaar M., Deriu M., Melis M., Molari A., Di Fonzo A., et al. LRRK2 mutations and Parkinson's disease in Sardinia-A Mediterranean genetic isolate. Parkinsonism Relat Disord 13 1 (2007) 17-21
23. Gaig C., Ezquerra M., Marti M.J., Munoz E., Valldeoriola F., and Tolosa. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance. Arch Neurol 63 3 (2006) 377-382
24. Bras J.M., Guerreiro R.J., Ribeiro M.H., Januario C., Morgadinho A., Oliveira C.R., et al. G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort. Mov Disord 20 12 (2005) 1653-1655
25. Toft M., Haugarvoll K., Ross O.A., Farrer M.J., and Aasly J.O. LRRK2 and Parkinson's disease in Norway. Acta Neurol Scand. Suppl 187 (2007) 72-75
26. Hernandez D.G., Paisan-Ruiz C., McInerney-Leo A., Jain S., Meyer-Lindenberg A., Evans E.W., et al. Clinical and positron emission tomography of Parkinson's disease caused by LRRK2. Ann Neurol 57 3 (2005) 453-456
27. Toft M., Sando S.B., Melquist S., Ross O.A., White L.R., Aasly J.O., et al. LRRK2 mutations are not common in Alzheimer's disease. Mech Ageing Dev 126 11 (2005) 1201-1205
28. Goldwurm S., Zini M., Di Fonzo A., De Gaspari D., Siri C., Simons E.J., et al. LRRK2 G2019S mutation and Parkinson's disease: a clinical, neuropsychological and neuropsychiatric study in a large Italian sample. Parkinsonism Relat Disord 12 7 (2006) 410-419
29. Ferreira J.J., Guedes L.C., Rosa M.M., Coelho M., van Doeselaar M., Schweiger D., et al. High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal. Mov Disord 22 8 (2007) 1194-1201